S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7120 +0.15%
AFTER HRS · 19:25 ET
Market ClerkRecap
Wed Oct 21 · after hours2 signals today106 insider buys this week · $305.5MCIRO short report next: Oct 31The week ahead
MB
INSIDER · TRDA · Entrada Therapeutics, Inc. · 10% OWNER

MPM BIOVENTURES 2018, L.P.

Every open-market transaction filed under this name, Aug 24 to Sep 9.

Filings
12
0 buys · 12 sells
Bought
—
open market, at cost
Sold
$3.6M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 9TRDAEntrada Therapeutics, Inc.10% ownerSell28,837$7.13$206K—
Sep 8TRDAEntrada Therapeutics, Inc.10% ownerSell192,500$7.41$1.4M—
Sep 4TRDAEntrada Therapeutics, Inc.10% ownerSell38,500$7.11$274K—
Sep 3TRDAEntrada Therapeutics, Inc.10% ownerSell32,263$7.17$231K—
Sep 2TRDAEntrada Therapeutics, Inc.10% ownerSell25,131$7.19$181K—
Sep 1TRDAEntrada Therapeutics, Inc.10% ownerSell29,088$7.06$205K—
Aug 31TRDAEntrada Therapeutics, Inc.10% ownerSell44,259$6.99$309K—
Aug 28TRDAEntrada Therapeutics, Inc.10% ownerSell3,733$7.01$26K—
Aug 27TRDAEntrada Therapeutics, Inc.10% ownerSell38,922$7.20$280K—
Aug 26TRDAEntrada Therapeutics, Inc.10% ownerSell14,569$7.06$103K—
Aug 25TRDAEntrada Therapeutics, Inc.10% ownerSell26,522$7.54$200K—
Aug 24TRDAEntrada Therapeutics, Inc.10% ownerSell21,623$7.34$159K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.